Cypherpunk Technologies

Cypherpunk Technologies EV/OCF

The EV/OCF (Enterprise Value to Operating Cash Flow) of Cypherpunk Technologies (CYPH) as of Oct 16, 2026 is 0.12. In the previous year, EV/OCF (Enterprise Value to Operating Cash Flow) was 0.70 — a change of -83.23% (lower).

EV/OCF

0.12

YoY

-83.23%

Last updated:

EV/OCF (Enterprise Value to Operating Cash Flow) of Cypherpunk Technologies is 2024 0.12 . EV/OCF (Enterprise Value to Operating Cash Flow) of Cypherpunk Technologies was 2023 0.70 . It decreases by -83.23% lower compared to the previous year.

The Cypherpunk Technologies EV/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/OCF
Date
EV/OCF
Jan 1, 2017
-0.65 USD
Jan 1, 2018
-0.92 USD
Jan 1, 2019
-1.35 USD
Jan 1, 2020
0.46 USD
Jan 1, 2021
2.12 USD
Jan 1, 2022
0.52 USD
Jan 1, 2023
0.70 USD
Jan 1, 2024
0.12 USD
The Cypherpunk Technologies EV/OCF history
YEAREV/OCFYoY
0.12-83.23%
0.70+34.89%
0.52-75.74%
2.12+365.26%
0.46-133.82%
-1.35+46.88%
-0.92+40.55%
-0.65-76.22%
-2.75-48.11%
-5.30-3.57%
-5.50—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cypherpunk Technologies Stock analysis

What does Cypherpunk Technologies do? Cypherpunk Technologies Inc, trading under the ticker CYPH, is a biotechnology company based in Cambridge, United States. The company has a small workforce of six employees. It went public with an IPO on January 24, 2017. The company's website is https://www.leaptx.com/. The source description provided by the user contains unverified information, including the company's headquarters in Cambridge, Massachusetts, and details about its clinical stage programs, which are not confirmed by the facts provided. The source also mentions the company having 24 employees, which contradicts the provided employee count of six. Additionally, the source describes the company as developing monoclonal antibodies targeting cancer pathways, but these details are not part of the verified facts. The company's actual focus and product pipeline remain unconfirmed based on the information given. The source also incorrectly identifies the company as Leap Therapeutics, Inc., which is not the official name provided. The website provided, https://www.leaptx.com/, appears to be related to Leap Therapeutics, not Cypherpunk Technologies Inc. Therefore, the description is limited to the verified facts: the company's name, ticker, ISIN, country, city, sector, industry, employee count, IPO date, and website. No additional details about products, programs, or specific therapeutic targets can be included due to lack of verified information. Cypherpunk Technologies is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Cypherpunk Technologies stock

EV/OCF (Enterprise Value to Operating Cash Flow) of Cypherpunk Technologies is 0.12 in 2024.

EV/OCF (Enterprise Value to Operating Cash Flow) of Cypherpunk Technologies changed from 0.70 to 0.12, representing a -83.23% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/OCF (Enterprise Value to Operating Cash Flow) Cypherpunk Technologies since 2006 – with annual values, charts, and detailed analysis.

EV/OCF compares enterprise value to operating cash flow, measuring how much investors pay per unit of cash generated from operations.

To evaluate EV/OCF (Enterprise Value to Operating Cash Flow)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/OCF (Enterprise Value to Operating Cash Flow).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/OCF (Enterprise Value to Operating Cash Flow)'s Cypherpunk Technologies with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Cypherpunk Technologies

All Key Metrics — Cypherpunk Technologies